Peripheral Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationGraft vs Host DiseaseHematologic NeoplasmsTransplantation ConditioningHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorTransplantation ChimeraGraft SurvivalBone Marrow TransplantationLeukapheresisTissue DonorsAntigens, CD34BusulfanVidarabineTransplantation, AutologousGraft vs Leukemia EffectTreatment OutcomeRecurrenceImmunosuppressive AgentsHistocompatibilityLeukemiaMyeloablative AgonistsHistocompatibility TestingBlood Component RemovalWhole-Body IrradiationSurvival AnalysisRetrospective StudiesChronic DiseaseT-LymphocytesHematopoietic Stem CellsStem CellsMelphalanHLA AntigensCyclophosphamideCombined Modality TherapyDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaStem Cell TransplantationBlood CellsAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaTransplantation ImmunologyLeukocytes, MononuclearTransplantation, IsogeneicLymphoma, Non-HodgkinRemission InductionBlood Cell CountCord Blood Stem Cell TransplantationEtoposideCyclosporineHematopoiesisLymphocytesTime FactorsFlow CytometryRecombinant ProteinsGraft vs Tumor EffectLymphocyte TransfusionAntineoplastic Agents, AlkylatingThiotepaLeukemia, Myeloid, AcuteAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunophenotypingLymphocyte ActivationLymphocyte DepletionInfectionBlood DonorsCytarabineSalvage TherapySurvival RateCell SeparationBone MarrowCells, CulturedLeukocyte CountAntigens, CDLymphocyte Culture Test, MixedLeukocyte TransfusionIsoantigensIfosfamideHodgkin DiseaseImmunosuppressionBone Marrow CellsBone Marrow PurgingPlatelet CountVincristineCytomegalovirus InfectionsNeoplasm, ResidualLymphomaImmunomagnetic SeparationMyelodysplastic SyndromesAcute DiseaseHematologic DiseasesNeoplasmsFeasibility StudiesPlatelet TransfusionSiblingsCarmustinePOEMS Syndrome